Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies.

Cookies policy

Data selected by 959 Name Kelevo

Original name

Strength

Marketing authorisation number

Marketing authorisation holder:

ATCvet code

Species

Kelevo

400 µg/tabl.

V/DCP/21/0033

Industrial Veterinaria, S.A., Spānija

QH03AA01

dogs; cats

Vairāk

Medicinal product information

Pharmaceutical form:	tablets
International name (active substance):	Levothyroxine sodium
Distribution category:	To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release	aniMedica GmbH, Vācija
Date of authorisation/renewal:	28-Jan-2022
Marketing authorisation valid until:	Unlimited time period
Marketing authorisation procedure:	DCP
Package leaflet:	[PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Labelling text:	[PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Summary of product characteristics:	[DOCX] Zāļu_informācija_ZA_M_LI (16-Jul-2025)

ID	Package size	Primary packaging	Labelling
V/DCP/21/0033-01	5	Alumīnija blisteris, 10 tablete	-
V/DCP/21/0033-02	10	Alumīnija blisteris, 25 tablete	-
V/DCP/21/0033-03	10	Alumīnija blisteris, 10 tablete	-
V/DCP/21/0033-04	25	Alumīnija blisteris, 10 tablete	-
V/DCP/21/0033-05	2	Alumīnija blisteris, 25 tablete	-
V/DCP/21/0033-06	4	Alumīnija blisteris, 25 tablete	-

Kelevo

200 µg/tabl.

V/DCP/21/0034

Industrial Veterinaria, S.A., Spānija

QH03AA01

dogs; cats

Vairāk

Pharmaceutical form:	tablets
International name (active substance):	Levothyroxine sodium
Distribution category:	To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release	aniMedica GmbH, Vācija
Date of authorisation/renewal:	28-Jan-2022
Marketing authorisation valid until:	Unlimited time period
Marketing authorisation procedure:	DCP
Package leaflet:	[PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Labelling text:	[PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Summary of product characteristics:	[DOCX] Zāļu_informācija_ZA_M_LI (16-Jul-2025)

ID	Package size	Primary packaging	Labelling
V/DCP/21/0034-01	5	Alumīnija blisteris, 10 tablete	-
V/DCP/21/0034-02	10	Alumīnija blisteris, 25 tablete	-
V/DCP/21/0034-03	10	Alumīnija blisteris, 10 tablete	-
V/DCP/21/0034-04	25	Alumīnija blisteris, 10 tablete	-
V/DCP/21/0034-05	2	Alumīnija blisteris, 25 tablete	-
V/DCP/21/0034-06	4	Alumīnija blisteris, 25 tablete	-

Kelevo

800 µg/tabl.

V/DCP/21/0032

Industrial Veterinaria, S.A., Spānija

QH03AA01

dogs

Pharmaceutical form:	tablets
International name (active substance):	Levothyroxine sodium
Distribution category:	To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release	aniMedica GmbH, Vācija
Date of authorisation/renewal:	28-Jan-2022
Marketing authorisation valid until:	Unlimited time period
Marketing authorisation procedure:	DCP
Package leaflet:	[PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Labelling text:	[PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Summary of product characteristics:	[DOCX] Zāļu_informācija_ZA_M_LI (16-Jul-2025)

ID	Package size	Primary packaging	Labelling
V/DCP/21/0032-01	5	Alumīnija blisteris, 10 tablete	-
V/DCP/21/0032-02	10	Alumīnija blisteris, 10 tablete	-
V/DCP/21/0032-03	10	Alumīnija blisteris, 25 tablete	-
V/DCP/21/0032-04	25	Alumīnija blisteris, 10 tablete	-
V/DCP/21/0032-05	2	Alumīnija blisteris, 25 tablete	-
V/DCP/21/0032-06	4	Alumīnija blisteris, 25 tablete	-

3 records · Download